Press Release
Panadol, the nation’s most sought after healthcare brand reaches out to pilgrims of Sri Pada
Provides free first aid services to thousands of pilgrims
Colombo, March 01: Panadol, the flagship brand of SmithKline Beecham (GlaxoSmithKline) and the nation’s most sought after pain reliever, held another successful medical camp, as a part of their CSR Programme, ‘Panadol Suwa Saviya’, to provide relief to the pilgrims visiting Sri Pada”. As a part of this activity, done in partnership in Red Cross, thousands of pilgrims were provided were much needed relief from pain and were offered first aid services, which helped them strengthen their bond with the brand.
Panadol Suwa Saviya relief camp provided relief to over 1,300 pilgrims, and the initiative is estimated to have seen the participation of over 220,000 pilgrims over a period of four days. Equipped with a range of medical facilities, the relief camp was located in Nallatanni, and provided free pain relief and first-aid services to all pilgrims present. The fully fledged camp was equipped with beds and other essential medical facilities, with trained personnel in attendance around the clock, in and around the premises. Panadol hosted their medical camp in collaboration with Red Cross who added their expertise to the quality of service offered, and together, they provided essential support to the pilgrims at no cost.
Speaking on this Panadol Suwa Saviya initiative, Sunil Mehra, Chairman/Managing Director, GlaxoSmithKline, said “As a flagship brand, Panadol has built a long-standing bond with all Sri Lankans and for the past 50 years, has become an essential part of their everyday lives. As we are all aware, important religious and cultural festivals bring thousands of people together. This is the time for prayers and time with family and friends. Any incident of pain can impact this experience. These special occasions are made easy with these medical camps and thus can help pilgrims participate in a joyful manner. Just as our many previously held Panadol Suwa Saviya medical camps during festivals have helped many consumers through time and meaningful relief, we strongly believe that our continued efforts reiterate our core principle of giving back to the community in the best way possible”.
Panadol has undertaken several CSR initiatives under the “Panadol Suwa Saviya” programme, and has held many relief camps and mobile first aid services during the most important religious and cultural festivals of the country, namely in places such as Anuradhapura, Mihinthale, Thanthirimale, Kandy, Nallur and Thalawila. The programme has been able to touch the lives of millions of Sri Lankans, further encouraging the brand to continue this service and enhance it every year.
Panadol is the flagship brand of GlaxoSmithKline, a multinational healthcare company that also manufacture and distribute household products such Viva, Horlicks, Sensodyne, Eno and Iodex. During its five decade long history in Sri Lanka, Panadol has been the driving force of several initiatives to promote safe and responsible use of medicine. Panadol is the first and only brand to introduce a child resistant cap to its liquid Paracetamol product range “Panadol for Children”. In 2012, a state of the art Panadol manufacturing facility in Ratmalana was established with an investment of Rs. 217 million, making it one of the largest Foreign Direct Investments in the pharmaceuticals sector in Sri Lanka.
About Smithkline Beecham Pvt, Ltd
SmithKline Beecham Pvt. Ltd is a subsidiary of GlaxoSmithKline (GSK) plc. of U.K, one of the world’s largest science based consumer healthcare companies. GSK’s purpose is to help people around the world to do more, feel better and live longer with everyday healthcare products. GSK owns some of the world’s best loved healthcare brands, successful in over 100 countries including Panadol, Sensodyne and Horlicks. The company also manufacture and distribute everyday healthcare products like Viva, Eno and Iodex.
About Panadol
Panadol is the flagship brand of SmithKline Beecham Pvt. Ltd. During its five decades in Sri Lanka, Panadol has introduced several unique initiatives to promote safe and responsible use of medicine. Panadol is the first and only brand in Sri Lanka to introduce a child resistant cap to its liquid Paracetamol product range “Panadol for Children”. It has also introduced the revolutionary Dosage by Weight Matrix for child medication. In 2012, a state of the art Panadol manufacturing facility in Ratmalana, Sri Lanka was established with an investment of Rs. 217 million, making it one of the largest Foreign Direct Investments in the pharmaceuticals sector in Sri Lanka.
Media Contacts
Keshani Gamage
Ogilvy Public Relations
Mobile: 0777 718851
Email: keshani.gamage@ogilvy.com
